A triazole-thiophene based compound with potential nonlinear optical properties and β-lactamase inhibitory activity to protect β-lactam antibiotics
Moreno-Fuquen, R. and Arango-Daravina, Kevin and Kennedy, Alan (2025) A triazole-thiophene based compound with potential nonlinear optical properties and β-lactamase inhibitory activity to protect β-lactam antibiotics. ChemistrySelect, 10 (43). e03401. ISSN 2365-6549 (https://doi.org/10.1002/slct.202503401)
Preview |
Text.
Filename: Moreno-Fuquen-etal-2025-A-triazole-thiophene-based-compound-with-potential-nonlinear-optical-properties_.pdf
Accepted Author Manuscript License:
Download (1MB)| Preview |
Abstract
A novel compound, (5-amino-3-(methylthio)-1H-1,2,4-triazole-1-yl)(thiophen-2-yl)methanone (TAT), combining 1,2,4-triazole and thiophene scaffolds, has been synthesized and characterized using crystallographic, spectroscopic, thermal, and computational methods. The crystalline packing of TAT is mainly controlled by hydrogen bonds, chalcogen bonds, C-H⋯π and π⋯π interactions, revealing the presence of R66(38), R33(17), and R22(8) fused rings. Hirshfeld surface analysis revealed a stable dimeric structure (DTAT), which was energetically favored by 70.16 kJ/mol, making it the basis for further analysis. Quantum chemical calculations indicated a small HOMO-LUMO gap and significant electronic delocalization in its dimeric structure. DTAT exhibited strong second-order nonlinear optical (NLO) potential, with hyperpolarizability 4.4 times that of KDP and 15 times higher than that of urea. Dispersion energy was dominant in the monomer, while electrostatics defined the dimer. Molecular docking revealed the interactions of TAT with serine β-lactamase, specifically targeting key residues and facilitating effective Zn²⁺ binding, which suggests inhibitory potential. DTAT also demonstrated good interaction with metallo-β-lactamase, supporting its role in enhancing the activity of β-lactam antibiotics. A bioavailability radar indicated favorable lipophilicity, polarity, and flexibility. Overall, DTAT is a promising candidate for NLO applications and β-lactamase inhibition.
ORCID iDs
Moreno-Fuquen, R., Arango-Daravina, Kevin and Kennedy, Alan
ORCID: https://orcid.org/0000-0003-3652-6015;
-
-
Item type: Article ID code: 94785 Dates: DateEvent17 November 2025Published12 November 2025Published Online22 October 2025Accepted11 June 2025SubmittedSubjects: Science > Chemistry
Medicine > Pharmacy and materia medica > Pharmaceutical chemistryDepartment: Faculty of Science > Pure and Applied Chemistry Depositing user: Pure Administrator Date deposited: 21 Nov 2025 15:16 Last modified: 30 Jan 2026 18:16 URI: https://strathprints.strath.ac.uk/id/eprint/94785
Tools
Tools






